Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 217 for “"TMZ"”.
-
Targeting rhabdomyosarcoma with temozolomide: how autophagy regulates TMZ-induced apoptosis in rhabdomyosarcoma cells
… RMS with the oral alkylating agent temozolomide (TMZ), alone or in combination with other drugs, has recently received considerable interest. However, the mechanism of action of TMZ remains unclear. The aim of this investigation was to determine if autophagy modulates TMZ-induced cell death in an …
-
Inhibition of YB-1 alone or in combination with TMZ may improve GBM treatment
… it plays roles in taxol (TXL) and temozolomide (TMZ) sensitivity. TXL is a commonly used anti-tumor drug and TMZ is the leading compound in GBM treatment. We evaluated YB-1 stable knock-down GBM cells sensitivity to these drugs both in monolayer and soft agar. Interestingly, we see a significant …
-
ASSESSMENT OF INTRACELLULAR REDOX-BALANCE ROLE IN TMZ-RESISTANCE-RELATED CYTOPROTECTIVE PATHWAYS IN GBM
… factors which are involved in resistance to TMZ treatment, HIF-1α emerges since it activates several pathways, among which angiogenesis and EMT. Beyond its primary alkylating power, TMZ can exerts other secondary effects within cells, as ER stress-mediated ROS release from mitochondria and …
-
Counteracting temozolomide (TMZ)-resistant glioblastoma (GBM) via inhibition of the cellular base excision repair pathway (BER)
… of surgery, radiation therapy and Temozolomide (TMZ) chemotherapy, GBM frequently recurs in a drug-resistant form. This work investigates how inhibition of the hyperactive Base Excision Repair (BER) pathway, with existing or newly developed inhibitors, could be beneficial to resensitize resistant …
-
Context-dependent roles of BCL2L13 in autophagy, mitochondrial respiration, ceramide remodeling, and temozolomide resistance in glioblastoma
… resection, radiotherapy, and temozolomide (TMZ) chemotherapy. Development of TMZ resistance remains a major therapeutic challenge and has been associated with altered autophagy, mitochondrial function, and sphingolipid metabolism. BCL-2-like protein 13 (BCL2L13), a mitochondria-localized …
-
Preventing the Emergence of Temozolomide Resistance in Glioblastoma by PARP Inhibition
Temozolomide (TMZ) is active against the subset of glioblastomas (GBMs) in which the O6-methylguanine DNA-methyltransferase (MGMT) gene is silenced by promoter methylation. Unfortunately, virtually all MGMT-methylated tumors acquire TMZ resistance and regrow in patients. In a preliminary study, we …
-
Preparation, stability testing and in vitro antiproliferative determination of ester and amide derivatives of Temozolomide
… glioblastoma multiforme (GBM) is temozolomide (TMZ). Tumour resistance to TMZ results in significantly limited clinical effectiveness. There is therefore an inherent need for alternatives to TMZ capable of overcoming resistance associated with MGMT and MMR. In the present study, a series ester …
-
Self-Assembling Peptide Hydrogel for Local Anticancer Prodrug Delivery in the Treatment of Glioblastoma Multiforme
… with the DNA alkylating agent, Temozolomide (TMZ), is commonly used as a first-line treatment for GBM. TMZ is an orally delivered drug that is known to be stable or inactive in the acidic pH environment of the stomach and begins to convert to its active form at a neutral pH in the bloodstream. …
-
Drug delivery systems to include liposomes and microparticles in order to aid treatment of glioma.
… out to investigate the effect of encapsulating TMZ and Patrin-2 into liposomes and microparticles separately in order to enhance the delivery. A validated HPLC system was used for the analysis of both TMZ and Patrin-2. First phase of our study involved the preparation of a delivery system of TMZ …
-
Targeting DNA Double-Strand Break Repair to Potentiate Radio- and Chemo Therapy of Glioblastoma
… followed by radiation and adjuvant temozolomide (TMZ) is the standard of care for glioblastoma (GBM). Not all GBMs respond to therapy, and most of them quickly acquire resistance to TMZ and recur. In order to develop more effective and rational treatments for GBM, it is crucial to understand the …
-
DLL4 and JAG1 in the Glioblastoma Response to Temozolomide Chemotherapy
… by radiotherapy and adjuvant temozolomide (TMZ) chemotherapy. Prognosis is poor, with a median survival of 14.6 months following diagnosis. Treatment often fails due to intrinsic or acquired TMZ resistance of a small population of cells termed glioma cancer stem cells (GCSCs). A promising …
-
Counteracting temozolomide resistance in glioblastoma multiforme (GBM) through suppression of the base excision repair (BER) pathway
… drug-resistant GBM. Methods and Materials TMZ sensitive/resistant GBM models with nuclear fluorescent were generated, and resistance was validated with growth, DNA damage and death assays. Furthermore, RNA/protein expressions were compared to identify modifications in TMZ-resistant cells; …
-
Functional role of C1Q-TNF related peptide 8 (CTRP8)-binding RXFP1 in brain tumors
… the protection of cells from temozolomide (TMZ)-induced DNA damage. TMZ chemoresistance is a common occurrence and a major cause for fatal outcome in GB. TMZ induced DNA damage is repaired by the base excision repair (BER) pathway. Impaired BER eventually leads to double strand DNA (dsDNA) …
-
Metabolomic Studies of Temozolomide Response in Patient-Derived Models of Glioblastoma
… primary brain tumour for which temozolomide (TMZ) remains a core component of first-line therapy as the only systemic drug with an established survival benefit in this setting. However, over half of patients exhibit intrinsic or acquired resistance and clinical tools remain limited for …
-
Investigating acquired temozolomide resistance in adult glioblastoma
… includes surgery, radiotherapy and temozolomide (TMZ), which causes three types of DNA methylation: O6-methylguanine (O<sup>6</sup>-meG), N7-methylguanine and N3-methyladenine. N-methylated lesions are mostly recognised and repaired by base excision repair (BER), while the most toxic DNA adduct is …
-
EVALUATING THE EFFECTS OF FASTING CONDITIONS IN COMBINATION WITH TEMOZOLOMIDE FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
… with the chemotherapeutic agent temozolomide (TMZ) and radiotherapy. O-6-methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein involved in TMZ resistance. Known as the Warburg effect, cancer cells will preferentially oxidize glucose to lactate in glycolysis. This less effective …
-
Locally Injectable Peptide Hydrogel for Conversion of Temozolomide and Codelivery of siRNA in Glioblastoma Multiforme Treatment
… a 5-year survival rate of 5.6%. Temozolomide (TMZ), the only chemotherapy FDA-approved for GBM treatment, is a hydrophobic prodrug that is stable in an acidic pH and begins converting to its active form at a physiological pH of 7.4. However, complete conversion of TMZ is observed only at a …
-
Circadian Regulation of Temozolomide Sensitivity in Glioblastoma
… the efficacy of the DNA alkylator Temozolomide (TMZ) on GBM in vitro and in vivo as a function of time of day. We found cell-intrinsic, daily rhythms in susceptibility of GBM tumor cells (mouse astrocytes deficient in NF1 and p53 signaling) to TMZ in vitro. The greatest TMZ-induced DNA damage …
-
Caractérisation et modulation de la résistance au témozolomide chez le glioblastome multiforme
… et de la chimiothérapie avec le témozolomide (TMZ). De nombreux mécanismes contribuant à une résistance innée ou acquise à cet agent thérapeutique ont été identifiés et peuvent mener à un échec du traitement. Cette étude entreprend une approche métabolomique pour caractériser des …
Page 1 of 11